Aclarion Operating Margin from 2010 to 2024
ACONW Stock | USD 0.04 0.00 0.00% |
Check Aclarion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aclarion's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 139.1 K or Interest Expense of 605.7 K, as well as many indicators such as Price To Sales Ratio of 22.45, Dividend Yield of 0.096 or Days Sales Outstanding of 128. Aclarion financial statements analysis is a perfect complement when working with Aclarion Valuation or Volatility modules.
Aclarion | Operating Margin |
Latest Aclarion's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Aclarion over the last few years. It is Aclarion's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aclarion's overall financial position and show how it may be relating to other accounts over time.
View | Last Reported (103.51) % | 10 Years Trend |
|
Operating Profit Margin |
Timeline |
Aclarion Operating Margin Regression Statistics
Arithmetic Mean | (124.44) | |
Coefficient Of Variation | (30.53) | |
Mean Deviation | 33.03 | |
Median | (149.21) | |
Standard Deviation | 37.99 | |
Sample Variance | 1,443 | |
Range | 100 | |
R-Value | 0.79 | |
Mean Square Error | 572.35 | |
R-Squared | 0.63 | |
Significance | 0.0004 | |
Slope | 6.75 | |
Total Sum of Squares | 20,205 |
Aclarion Operating Margin History
About Aclarion Financial Statements
Aclarion investors use historical fundamental indicators, such as Aclarion's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Aclarion. Please read more on our technical analysis and fundamental analysis pages.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in the United States. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California. Aclarion Inc operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aclarion Stock Analysis
When running Aclarion's price analysis, check to measure Aclarion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclarion is operating at the current time. Most of Aclarion's value examination focuses on studying past and present price action to predict the probability of Aclarion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclarion's price. Additionally, you may evaluate how the addition of Aclarion to your portfolios can decrease your overall portfolio volatility.